Abstract
Ecabet, an antiulcer drug, is reported to be effective in patients with ulcerative colitis. We investigated the effect of ecabet enema on ulcerative colitis in rats and some mechanisms underlying this effect. In vivo ecabet enema showed a therapeutic effect in the rat ulcerative colitis model induced by dextran sodium sulfate in the drinking water. The amount of ecabet bound to damaged mucosa was higher than that bound to normal mucosa 30 min after intrarectal administration. In vitro ecabet accelerated the restitution of epithelial cells, which was not affected by a TGF-β antibody. Ecabet inhibited the leukotriene B4 production and 5-lipoxygenase activity in human neutrophils. In conclusion, ecabet enema showed a therapeutic effect in rats with ulcerative colitis. This effect may be attributable to the high binding affinity for damaged mucosa, the acceleration of restitution, and the inhibition of leukotriene B4 production.
Similar content being viewed by others
References
Ito Y, Sugawara Y, Takaiti O, Nakamura S: Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthre- necarboxylic acid 6-sodium salt pentahydrate (TA-2711). II. Distribution in the rat stomach. J Pharmacobiodyn 14(9):547–554, 1991
Ito Y, Fukushima T, Sugawara Y, Takaiti O, Nakamura S: Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)- 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). I. Disposition, metabolism and protein binding in rats and dogs. J Pharmacobiodyn 14(9):533–546, 1991
Furukawa O, Kume E, Sugamoto S, Kawauchi S, Takeuchi K: Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro. Digestion 62(2–3):116–125, 2000
Ichikawa T, Ishihara K, Hayashida H, Hiruma H, Saigenji K, Hotta K: Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa. Dig Dis Sci 45(3):606–613, 2000
Onoda Y, Takido M, Magaribuchi T, Tamaki H: Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats. Jpn J Pharmacol 52(4):631–638, 1990
Kono T, Nomura M, Kasai S, Kohgo Y: Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study. Am J Gastroenterol 96(3):793–797, 2001
Kimura I, Kawasaki M, Nagahama S, Matsuda A, Kataoka M, Kokuba Y: Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats. Arzneimittelforschung 48(11):1091–1096, 1998
Ciacci C, Lind SE, Podolsky DK: Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105(1):93–101, 1993
Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77–89, 1968
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254, 1976
Kinoshita M, Kume E, Tamaki H: Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium. J Pharmacol Exp Ther 275(1):494–501, 1995
Kinoshita M, Iwasaki H, Yasoshima A, Tamaki H: Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats. Biol Pharm Bull 16(12):1220–1225, 1993
Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJ, Moncada S: Nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Lancet 342(8867):338–340, 1993
Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, Caprilli R: Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 44(7):1458–1475, 1999
Kawakami K, Yasuda M, Ishii K, Kokusenya Y, Sato T: A kinetic study of protein binding to ecabet sodium using quartz-crystal microbalance. Chem Pharm Bull (Tokyo) 47(7):919–922, 1999
Dignass AU: Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 7(1):68–77, 2001
Dignass AU, Podolsky DK: Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105(5):1323–1332, 1993
Laursen LS, Naesdal J, Bukhave K, Lauritsen K, Rask-Madsen J: Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet 335(8691):683–685, 1990
Sharon P, Stenson WF: Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86(3):453–460, 1984
Kimura I, Nagahama S, Kawasaki M, Kataoka M, Sato M: Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (3). Nippon Yakurigaku Zasshi 108(5):259–266, 1996
Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286(5770):264–265, 1980
Eliakim R, Karmeli F, Chorev M, Okon E, Rachmilewitz D: Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis. Scand J Gastroenterol 27(11):968–972, 1992
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Noto, T., Yamada, H., Inui, T. et al. Therapeutic Effects of Ecabet Sodium, an Antiulcer Drug, on Dextran Sodium Sulfate–Induced Ulcerative Colitis in Rats. Dig Dis Sci 50, 922–927 (2005). https://doi.org/10.1007/s10620-005-2665-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2665-y